Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats
Always check the expiry date on the product packaging and use before it
it's quick and simple
Pros: Extended half-life compared to unmodified MGF, in theory allowing fewer, more practical dosing intervals Mechanism aligns with well-studied endogenous muscle-repair biology (satellite cell activation, IGF-1 pathway) Widely available from research-chemical vendors for lab/research purposes Cons: No FDA approval, no completed human clinical trials, and no regulator-reviewed safety or efficacy data Prohibited in competitive sport under WADA growth-factor rules Product quality and purity vary significantly between unregulated research-chemical suppliers Side Effects: Not well characterized due to the absence of an approved label
US$ 24.00
US$ 21.39
US$ 24.43
US$ 23.54
US$ 22.04
US$ 28.07
US$ 27.84
US$ 22.75
US$ 22.94
US$ 23.88
US$ 23.98
